Syncom Healthcare (Delisted) share price

BSE: 533157Pharmaceuticals & Biotechnology

Syncom Healthcare Limited · Face value ₹10 · Listed Feb 2010

Last traded ₹4.20 on 28 Jun 2021

Delisted on 14 Jan 2022.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

  1. Sep 2021

  2. Aug 2021

Share price history

Daily closes since Feb 2010, BSE closes Feb 2010 to Jul 2010, in Aug 2013, in Aug 2013, in Aug 2013, in Nov 2013, in Nov 2013, in Dec 2013 and in Mar 2020, adjusted for splits and bonuses

Daily close, ₹ per share

Q1 results, quarter to Jun 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.35 Cr+10.1% on a year ago · −22.5% on the quarter before
Operating profit
−₹0.78 Cr
Net profit
−₹1.11 Cr
Earnings per share
−₹0.28
Operating margin
−222.0%
Net margin
−314.1%

From revenue to net profit, ₹ crore

  1. Revenue0.4
  2. Materials and goods−0.3
  3. Employee costs−0.6
  4. Other expenses−0.2
  5. Operating profit−0.8
  6. Depreciation−0.4
  7. Other income+0.1
  8. Finance costs0.0
  9. Profit before tax−1.1
  10. Tax0.0
  11. Net profit−1.1

Syncom Healthcare results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2021. Results for the quarter to Sep 2021 were due by 14 Nov 2021, 45 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss
15−0.8Sep 1817−0.3Dec 1812−9.0Mar 1912−0.8Jun 194.60.0Sep 191.0−1.2Dec 190.2−9.7Mar 200.3−1.5Jun 200.6−1.1Sep 200.5−1.3Dec 200.5−1.1Mar 210.4−1.1Jun 21
A loss in 12 of the 12 quarters shown

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
12.2%−6,414.4%2.0%−12.0%−1.4%12.2%−68.4%−1,014.6%−309.8%−95.3%−185.1%−197.7%−222.0%−5.0%−1.6%−76.7%−6.5%−0.4%−126.4%−6,414.4%−468.6%−178.0%−279.9%−234.7%−314.1%Sep 18Mar 19Sep 19Mar 20Sep 20Mar 21Jun 21
₹ croreSep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Q1Sep 2018Dec 2018Q3Mar 2019Jun 2019Q1Sep 2019Dec 2019Q3Mar 2020Jun 2020Q1Sep 2020Dec 2020Q3Mar 2021Jun 2021Q1
Revenue from operations16.313.46.75.312.512.212.012.915.017.511.712.24.61.00.20.30.60.50.50.4
–14.57.38.315.012.511.413.7–17.113.112.34.01.61.71.31.21.31.41.1
Materials and goods bought12.39.33.23.19.96.44.87.48.69.97.46.92.70.50.50.70.60.70.60.3
Employee costs–2.61.62.22.72.73.02.9–3.02.72.71.00.80.70.40.40.40.40.6
Other expenses–2.72.53.02.53.33.53.4–4.22.92.70.30.30.50.20.20.20.30.2
Operating profit before depreciation–−1.1−0.6−3.0−2.5−0.30.6−0.8–0.4−1.4−0.20.6−0.7−1.5−1.0−0.6−0.8−0.9−0.8
Operating margin–−8.5%−9.3%−56.5%−19.9%−2.6%5.1%−5.8%–2.0%−12.0%−1.4%12.2%−68.4%−1,014.6%−309.8%−95.3%−185.1%−197.7%−222.0%
Depreciation and amortisation1.11.12.30.90.91.00.90.7–0.80.70.60.60.60.60.50.60.40.40.4
Other income1.20.80.0–0.20.00.10.10.00.20.00.00.10.10.00.00.10.00.30.1
Finance costs0.70.80.80.00.20.00.00.00.00.10.30.10.10.00.00.00.00.00.00.0
Profit before one-off items and tax–−2.3−3.7−3.9−3.4−1.3−0.2−1.5−0.8−0.3−2.4−0.80.0−1.2−2.1−1.5−1.1−1.3−1.1−1.1
One-off items–−4.1−8.7−43.9−12.8–−0.10.10.00.0−6.60.00.00.0−7.60.00.00.00.00.0
Profit before tax−56.1−6.3−12.5−47.8−16.2−1.3−0.3−1.4−0.8−0.3−9.0−0.80.0−1.2−9.7−1.5−1.1−1.3−1.1−1.1
−1.10.97.9––––0.0–0.00.00.00.00.00.00.00.00.00.00.0
Net profit−55.1−7.2−20.4−47.8−16.2−1.3−0.3−1.4−0.8−0.3−9.0−0.80.0−1.2−9.7−1.5−1.1−1.3−1.1−1.1
Other comprehensive income–––––––0.0–0.00.00.00.00.00.20.00.00.00.00.0
Total comprehensive income–––––––−1.4–−0.3−8.9−0.80.0−1.2−9.5−1.5−1.1−1.3−1.1−1.1
Net margin−337.5%−54.0%−305.0%−903.4%−129.4%−10.3%−2.4%−10.6%−5.0%−1.6%−76.7%−6.5%−0.4%−126.4%−6,414.4%−468.6%−178.0%−279.9%−234.7%−314.1%
Earnings per share−₹13.77−₹1.80−₹5.09−₹11.95−₹4.06−₹0.32−₹0.05−₹0.34−₹0.19−₹0.07−₹2.23−₹0.40−₹0.20−₹0.51−₹2.88−₹0.37−₹0.64−₹0.32−₹0.27−₹0.28
Diluted earnings per share−₹13.77−₹1.80−₹5.09−₹11.95−₹4.06−₹0.32−₹0.05−₹0.34−₹0.19−₹0.07−₹2.23−₹0.40−₹0.20−₹0.51−₹2.88−₹0.04−₹0.64−₹0.32−₹0.27−₹0.28
Earnings per share in rupees, restated for later splits and bonuses.

The quarters either side of a change of basis do not compare. From the quarter to Mar 2020, the company's revenue for the year to Mar 2020, ₹20 Cr, differs from its quarters added, ₹18 Cr.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
860.2Mar 12940.2Mar 1364−4.6Mar 1462−3.8Mar 1563−3.5Mar 1653−84Mar 1742−66Mar 1857−1124Mar 1920−1224Mar 201.8−4.924Mar 21
A loss in 8 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
4.0%−268.0%2.0%4.0%−4.6%2.5%0.2%−4.3%−12.3%−3.1%−9.2%−180.4%0.2%0.2%−7.2%−6.2%−5.6%−157.6%−156.6%−19.9%−58.7%−268.0%Mar 12Mar 14Mar 16Mar 18Mar 20Mar 21

The years either side of a change of basis do not compare. From the year to Mar 2020, the company's revenue for that year, ₹20 Cr, differs from its quarters added, ₹18 Cr.

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1.8
  2. Materials and goods−2.6
  3. Employee costs−1.7
  4. Other expenses−0.9
  5. Operating profit−3.3
  6. Depreciation−2.0
  7. Other income+0.4
  8. One-off items0.0
  9. Finance costs0.0
  10. Profit before tax−4.9
  11. Tax0.0
  12. Net profit−4.9

What the company owns

  • Plant, investments and other assets₹12 Cr
  • Cash and bank₹4 Cr
  • Inventory₹0 Cr
  • Receivables₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹24 Cr
  • Owed to suppliers₹5 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2021, the latest four quarters added.

₹ croreMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Jun 2021Twelve months
Revenue from operations85.894.163.661.962.953.241.857.120.01.81.9
84.190.466.560.362.855.547.058.921.85.15.0
Materials and goods bought37.543.67.18.343.935.724.233.312.82.62.2
Employee costs––––9.19.310.711.65.21.71.9
Other expenses––––9.810.512.113.93.90.90.9
Operating profit before depreciation1.73.8−2.91.60.1−2.3−5.2−1.8−1.8−3.3−3.1
Operating margin2.0%4.0%−4.6%2.5%0.2%−4.3%−12.3%−3.1%−9.2%−180.4%−166.0%
Materials, % of revenue––––69.8%67.1%57.8%58.4%64.0%140.5%118.1%
Employee costs, % of revenue––––14.5%17.5%25.5%20.3%25.8%91.7%101.2%
Other expenses, % of revenue––––15.5%19.7%29.0%24.4%19.3%48.2%46.7%
Depreciation and amortisation2.32.33.85.34.15.63.72.92.32.01.9
Operating profit after depreciation−0.61.5−6.7−3.8−4.0−7.9−8.9−4.7−4.1−5.3−4.9
Other income2.82.43.13.03.02.20.40.30.30.40.4
Finance costs2.53.74.24.63.33.10.30.40.30.00.0
Profit before one-off items and tax−0.20.2−7.8−5.4−4.3−8.7−8.8−4.9−4.1−4.9−4.5
One-off items–––––−67.3−56.7−6.5−7.60.00.0
Profit before tax−0.20.2−7.8−5.4−4.3−76.0−65.5−11.4−11.7−4.9−4.5
0.80.0−3.2−1.5−0.87.9–0.00.00.00.0
Net profit0.20.2−4.6−3.8−3.5−83.9−65.5−11.4−11.7−4.9−4.5
Other comprehensive income–––––––0.00.20.00.0
Total comprehensive income–––––––−11.3−11.5−4.9−4.5
Net margin0.2%0.2%−7.2%−6.2%−5.6%−157.6%−156.6%−19.9%−58.7%−268.0%−242.3%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2012, Mar 2013, Mar 2014 and Mar 2015 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021
−0.9−12.4−17.3
Share capital40.040.040.0
Reserves−40.9−52.4−57.3
23.923.724.2
38.118.221.6
12.212.012.1
Total assets49.517.816.4
15.113.110.8
34.44.75.5
Net debt22.522.520.1
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021
2.32
2.45
5.34
Receivables0.09
Inventories1.57
Payables−0.24
Other working capital3.92
Capital spending0.00
Free cash flow2.32
−2.94
0.48
Dividends paid0.00
Shares bought back0.00
Shares issued0.00
Net change in cash−0.14
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Earnings per share₹0.05₹0.06––−₹0.88−₹20.97−₹16.38−₹2.83−₹2.88−₹1.23
Diluted earnings per share₹0.05₹0.06––−₹0.88−₹20.97−₹16.38−₹2.83−₹2.88−₹1.23
Book value per share–––––––−₹0.23−₹3.10−₹4.33
Shareholder yield–––––––––0.0%
Market cap at the year end (₹ crore)54.639.026.2–24.622.8–8.62.29.2

Ratios

Standalone, years to March.

RatioMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue growth13.6%9.7%−32.4%−2.7%1.7%−15.4%−21.4%36.4%–−90.8%
Operating profit growth−68.1%114.9%––−91.0%–––––
Net profit growth−92.9%25.8%––––––––
Earnings per share growth−94.2%20.0%––––––––
–––––––1,259.4%176.0%33.0%
––––––––−1,083.5 pts−143.0 pts
From the net margin––––––––2,449.7 pts627.5 pts
From asset turnover––––––––−1,801.4 pts−658.5 pts
From borrowing––––––––−1,731.8 pts−112.0 pts
Return on capital employed–––––––−20.5%−36.7%−77.3%
Interest cover–0.4––––––––
Receivable days–––––––114532
Inventory days–––––––785763
Payable days–––––––253156739
Cash conversion cycle, days–––––––−61−94−644
Working capital days–––––––45−49−1,528
Asset turnover–––––––1.150.590.11
Assets per rupee of net worth–––––––−54.77−5.05−1.15
Sales per rupee of plant–––––––4.421.790.20
Capital spending to depreciation–––––––––0.00
Plant being built, % of plant in use–––––––0.0%0.0%0.0%
Interest cover is left blank for the years to Mar 2012, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018, Mar 2019, Mar 2020 and Mar 2021: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2019, Mar 2020 and Mar 2021: net worth is below zero, so there is no shareholders' money to set the borrowings against. Revenue growth is left blank for the year to Mar 2020: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Return on assets, latest year
−28.7%
Measure10 years5 years3 years
Return on equity, average––489.5%
Return on capital employed, average––−44.8%
Operating margin, average−20.5%−41.8%−64.2%
Net margin, average−67.9%−132.2%−115.5%
Asset turnover, average––0.62
Cash conversion cycle, days, average––−266

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2021.

₹ croreLatest year
Cash from operations2.32
Cash from investing−2.94
Cash from financing0.48
Capital spending0.00
Dividends paid0.00
Shares bought back0.00
Shares issued for cash0.00
Borrowings raised0.00
Borrowings repaid0.51

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Piotroski score, out of 9Published threshold 3 points out of 9––––––––3
Altman Z-scorePublished threshold 1.81––––––−0.72−5.98−6.78
Beneish M-scorePublished threshold −1.78––––––––1.15
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––––––−25.04
Receivables growth less revenue growthOur threshold 0 percentage points–––––––−33.5954.57
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––––−9.982.03
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––––––−33.52−23.52
Assets under construction, years of additionsOur threshold 2 years of additions–––––––0.000.00
Effective tax ratePublished threshold 17.16 per cent−10.38––––––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2021 the company reports one business segment, Manufacture of Drugs, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2021, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year+318.2%––0.0%
3 years−20.3%––0.0%
5 years−17.9%––0.0%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.

Syncom Healthcare share price by year

Each calendar year to 2021.

YearClose at year endChangeHighest closeLowest close
20214.20+64.7%5.352.25
2020BSE close2.55+183.3%3.450.40
20190.90−72.3%3.400.75
20183.25−53.2%8.202.50
20176.95+11.2%6.954.30
20166.25−41.3%14.855.65
201510.65+52.1%12.004.80
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2021 close is its last trade, on 28 Jun 2021.

Recent sessions

The 10 trading days to 28 Jun 2021, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
28 Jun 20214.104.303.954.204.053,32,739
25 Jun 20214.404.404.004.154.143,59,174
24 Jun 20214.204.204.204.204.201,65,824
23 Jun 20213.704.003.704.003.873,51,582
22 Jun 20213.853.853.853.853.851,99,023
21 Jun 20214.054.054.054.054.051,89,465
18 Jun 20214.254.254.254.254.2539,952
17 Jun 20214.454.454.454.454.4584,018
16 Jun 20214.654.654.654.654.6591,076
15 Jun 20214.854.854.854.854.851,03,908
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-dateEventPrice factorWhat happened
24 Mar 2020Price move–Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
23 Mar 2020Price move–Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
Each event is noted and not adjusted for.

Company details

BSE code
533157
ISIN
INE602K01014
Industry
Pharmaceuticals & Biotechnology
Former symbols
SYNCOM
CIN
L51397MH2002PLC136652
Corporate identity number, the registrar of companies' code for it
Incorporated
2002
Registered office
Shop No. F-44, 1st Floor, Shagun Arcade Co-operative Society Limited, A. K. Vaidya Marg, Opp HDFC Bank, Malad (East), Mumbai 400097, Maharashtra
Share registrar
Link Intime India Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments